Effective vendor selection and contracting is critical to support regulatory information management capabilities that increasingly lie at the heart of quality and clinical processes. Romuald…
As trials become increasingly complex, companies share how leaving behind legacy EDC systems can save thousands of hours during study build and testing. In today’s…
The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD and this number is…
In the dynamic landscape of biotechnology, ICON’s recent survey of over 100 leaders from the biotech industry dissects the challenges and opportunities faced by biotech…
We’re in a new era of biotech, defined by the interplay between biology, data and AI. And it’s the enabling technologies — the connected instruments,…
Did you know that it takes approximately seven years to develop and bring a new drug to market? However, this time can be significantly reduced…
Smart analytics applied to real-world data are increasingly enabling companies to track adverse effects, while at the same time identifying opportunities for drug repurposing. ArisGlobal’s…
The breakneck pace of digital transformation spurred by COVID-19 continued to reshape the life sciences landscape in 2023. Rather than a single watershed moment, this…
Arriello’s Kate Coleman discusses how best to tackle the five key priorities for getting the most from your approach to quality and risk in 2024….
The new Third-Party Audit Report Library (3PARL®) consortium, founded by Rephine and Eurofins Healthcare, aims to set a benchmark for life sciences manufacturing supply chain…
